Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
12:01
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

51st ERA-EDTA CONGRESS

 

31 May - 3 June 2014 AMSTERDAM
FAQs
   
Discussion forum - 51st ERA-EDTA CONGRESS
    Topic - M) Dialysis. M5) Anaemia in CKD 5D.

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER.
 

Poster: 488
Visits: 33
Title: LOW LEVELS OF SERUM FERRITIN ARE ASSOCIATED WITH GOOD PROGNOSIS IN PATIENTS ON HAEMODIALYSIS
Authors: Chie Ogawa ,
Centre: Maeda Institute of Renal Research

You must be registered to reply or comment.

LOW LEVELS OF SERUM FERRITIN ARE ASSOCIATED WITH GOOD PROGNOSIS IN PATIENTS ON HAEMODIALYSIS

Chie Ogawa
Thread initiator
Subspeciality
Reg: 5/13/2014 6:31:00 AM
Comment# 1
Control of iron storage is an important therapeutic measure for anaemia in haemodialysis (HD) patients. Oxidative stress due to excessive iron (Fe) supplementation has been associated with atherosclerosis, infection, myocardial infarction, and malignancy. As such, taking particular care to avoid high ferritin levels in the setting of anaemia is an important part of care for those on HD, though optimal levels remain unclear, In order to clarify the appropriate level of serum ferritin, we investigated the relationships between ferritin level, hemoglobin (Hb), and mortality in HD patients.

Comment added on 5/13/2014 6:31:00 AM 
     
You must be registered to reply or comment.



Most viewed poster for this congress
Poster: 7
Visits: 477
Title: SEVERE SYMPTOMATIC ACUTE HYPONATREMIA IN TRAUMATIC BRAIN INJURY RESPONDS VERY RAPIDLY SINGLE 15 MG DOSE OF TOLVAPTAN: A MAYO CLINIC HEALTH SYSTEM HOSPITAL EXPERIENCE - NEED FOR CAUTION WITH TOLVAPTAN IN YOUNGER PATIENTS WITH PRESERVED RENAL FUNCTION
Authors: MACAULAY ONUIGBO ,
Centre: MAYO CLINIC, ROCHESTER & MAYO CLINIC HEALTH SYSTEM, EAU CLAIRE

Poster most viewed in this topic
Poster: 504
Visits: 165
Title: CAN THE USE OF A NOVEL DIALYSIS BLOODLINE INCREASE HAEMOGLOBIN AND REDUCE ERYTHROPOIETIN DOSES? RESULTS OF A PILOT, CROSSOVER, CLINICAL AUDIT.
Authors: Iain Macdougall , Adam Rumjon,1 Emmanuel Mangahis,1 Leela Goldstein,1 Thomas Ryzlewicz,2 Franz-Ferdinand Becker,2 William Kilgallon.2 1Renal Unit, Kings College Hospital, London, United Kingdom; 2 Oxyless Ltd, Reading, United Kingdom.
Centre: 1Renal Unit, Kings College Hospital, London, United Kingdom; 2 Oxyless Ltd, Reading, United Kingdom.


 








PosterSessionOnline
Logo Draft
 
Logo Cert